129 results on '"Hallupp, Marianne"'
Search Results
2. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies
3. TDP-43 subcellular mislocalisation is correlated with loss of optineurin binding for frontotemporal dementia and amyotrophic lateral sclerosis associated TBK1 missense variants
4. Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis?
5. DNA methylation of the MAPT gene in Parkinsonʼs disease cohorts and modulation by vitamin E In Vitro
6. Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies
7. Rapid and automated quantification of TDP-43 and FUS mislocalisation for screening of frontotemporal dementia and amyotrophic lateral sclerosis gene variants
8. Genetic Polymorphisms in Sigma-1 Receptor and Apolipoprotein E Interact to Influence the Severity of Alzheimerʼs Disease
9. Effects of the novel FTD‐ALS gene CYLD on cell death mechanisms
10. Reply: CYLD variants in frontotemporal dementia associated with severe memory impairment in a Portuguese cohort
11. Presenilin-1 Mutation L271V Results in Altered Exon 8 Splicing and Alzheimer's Disease with Non-cored Plaques and No Neuritic Dystrophy
12. This title is unavailable for guests, please login to see more information.
13. This title is unavailable for guests, please login to see more information.
14. Effect of Fluvoxamine on Amyloid-β Peptide Generation and Memory
15. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies
16. CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis.
17. Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease
18. Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer’s disease
19. IsCHCHD10Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis?: Figure 1
20. Effect of Fluvoxamine on Amyloid-β Peptide Generation and Memory.
21. DNA methylation of theMAPTgene in Parkinson's disease cohorts and modulation by vitamin EIn Vitro
22. C9ORF72 Repeat Expansion in Australian and Spanish Frontotemporal Dementia Patients
23. Endogenous progesterone levels and frontotemporal dementia: modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model
24. P1-285: Sigma non-opioid intracellular receptor 1 and neurodegeneration: prevalence of mutations and therapeutic implications
25. P4-304: SIGMAR1 Association Analysis With Dementia And Parkinsonism Phenotypes
26. Glycogen synthase kinase-3β and tau genes interact in Alzheimer's disease
27. No association of spastic paraparesis genes in PSEN1 Alzheimer's disease with spastic paraparesis
28. P3-312: Functional consequences of tau haplotype and subhaplotypes in human brains
29. P1-332: Glycogen synthase kinase -3 beta polymorphisms interact with Tau haplotypes in Alzheimer's disease
30. GSK3B polymorphisms alter transcription and splicing in Parkinson's disease
31. Tau haplotypes regulate transcription and are associated with Parkinson's disease
32. Intraneuronal advanced glycation endproducts in presenilin-1 Alzheimer??s disease
33. Variable phenotype of Alzheimer's disease with spastic paraparesis
34. Variable presentation of Alzheimer's disease and/or spastic paraparesis phenotypes in pedigrees with a novel PS-1 exon 9 gene deletion or exon 9 splice acceptor mutations
35. Novel Leu723Pro amyloid precursor protein mutation increases amyloid β42(43) peptide levels and induces apoptosis
36. Novel Leu723Pro amyloid precursor protein mutation increases amyloid ?42(43) peptide levels and induces apoptosis
37. Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimerʼs disease
38. Localization of frontotemporal dementia with parkinsonism in an Australian kindred to chromosome 17q21-22
39. Two novel (M233T and ρ278T) presenilin-1 mutations in early-onset Alzheimerʼs disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype
40. Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer’s disease
41. C9ORF72 Repeat Expansion in Australian and Spanish Frontotemporal Dementia Patients.
42. C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts.
43. Novel Leu723Pro amyloid precursor protein mutation increases amyloid beta42(43) peptide levels and induces apoptosis.
44. Rapid and automated quantification of TDP‐43 and FUS mislocalisation for screening of frontotemporal dementia and amyotrophic lateral sclerosis gene variants.
45. C9ORF72repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts
46. GSK3Bpolymorphisms alter transcription and splicing in Parkinson's disease
47. SIGMAR1 Association Analysis With Dementia And Parkinsonism Phenotypes
48. Two novel M233T and ρ278T presenilin1 mutations in earlyonset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin1 mutations with a novel phenotype
49. Two novel presenilin1 mutations Ser169Leu and Pro436Gln associated with very early onset Alzheimer's disease
50. No association of spastic paraparesis genes in PSEN1Alzheimer's disease with spastic paraparesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.